[1] |
Shan Ren,Mi-Jin P,HONGKEE S,et al. Effect of pharmaceutical excipients on aqueous stability of rabeprazole sodium[J]. International Journal of Pharmaceutics,2008,305(1/2):197-204.
|
[2] |
GARCIA C V,PAIM C S,STEPPE M,et al. Development and validation of a dissolution test for rabeprazole sodium in coated tablets[J]. Journal of Pharmaceutical and Biomedical Analysis,2006,41(3):833-837.
|
[3] |
MIURA M,TADA H,SRTOH S. Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction[J]. Journal of Pharmaceutical and Biomedical Analysis,2006,41(2):565-570.
|
[4] |
RAO R N,RAJU A N,NAGARAJU D. Enantiospecific resolution of rabeprazole by liquid chromatography on amylose-derived chiral stationary phase using photo diode array and polarimetric detectors in series[J]. Talanta,2006,74(4):805-810.
|
[5] |
RAM P,GHANTA M R,MADHUSUDAN R G,et al. An improved process for the production of rabeprazole sodium substantially free from the impurities[J]. Organic Process Research and Development,2009,13(5):896-899.
|
[6] |
陈敖,王智慧.雷贝拉唑的合成[J].精细与专用化学品,2010,18(2):28-29.
|
[7] |
邱飞,刁勇.雷贝拉唑钠的合成[J].中国医药工业杂志,2010,41(1):9-10.
|
[8] |
鲁亚洲,牛犇,陈严波.质子泵抑制剂雷贝拉唑钠的合成[J].化工时刊,2011,25(8):46-48.
|
[9] |
USHIKU S S,NIIHARI N U,TORIDE S M,et al. Pyridine derives having anti-ulcerative activity: US,5045552[P]. 1991-09-03.
|
[10] |
LARSSON E,STENHEDE U J,SORENSEN H,et al. Process for synthesis of substituted sulphoxides: WO,9602535A1[P]. 1996-02-01.
|
[11] |
徐宝财,王关兴,周雅文.高对映体选择性制备(S)-雷贝拉唑的方法:中国,101157686A[P]. 2008-04-09.
|
[12] |
徐宝财.雷贝拉唑钠对映体的不对称合成[D].北京:北京工商大学,2008.
|
[13] |
金薇,杨永健,彭兴盛,等.雷贝拉唑钠对映体在α1-酸性糖蛋白柱上的手性拆分[J].药物分析杂志,2006,26(2):1715-1717.
|
[14] |
JX20080210国家食品药品监督管理局进口药品注册标准 埃索美拉唑钠[S].
|